Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
1.78
0.12 (7.23%)
At close: Sep 26, 2025, 11:08 AM
7.23% (1D)
| Bid | 1.29 |
| Market Cap | 59.25M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -67.81M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -0.81 |
| Forward PE | -1.67 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 2.12 |
| Volume | 113,366 |
| Avg. Volume (20D) | 706,626 |
| Open | 1.66 |
| Previous Close | 1.66 |
| Day's Range | 1.62 - 1.79 |
| 52-Week Range | 0.24 - 3.98 |
| Beta | 0.74 |
| Ex-Dividend Date | n/a |
About RLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RLMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
-9.03%
Relmada Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
